We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biocircuits BIOC
BIOC 6.520+4.0%10:49 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Robinett who wrote (49)7/23/1997 8:44:00 AM
From: Craig Rodkin   of 65

The only good news (and it's at face value only) is BIOC per share loss will be lower this quarter (dilution of stock).

Bad news time. The $5m July financing probably will last until Q4; this is providing that BIOC pick up sales of 80 units (400k) for Q2 and 200 units ($1.2m) for Q3. If and only if BIOC reaches these figures and they have no delays in manufacturing (Sept 1996), do they have an actual shot at staying alive without further financing.

During the readings what really surprised me was the total accumulated debt. On Dec. 31 it was $51.5m and on March 31 it was $55.1m.

BD won't help either. The "hand shake" contract doesn't start until 1998.

This stock might be good for rides from 3/4 to 1-1/2. I'm in at 7/8 now and will take profits on the next run. Then buy back when it trickles down again. I figure BIOC has 2-3 good runs left.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext